Immunohistochemical study on transforming growth factor-beta1 expression in liver fibrosis of Down's syndrome with transient abnormal myelopoiesis
- 1 April 1999
- journal article
- case report
- Published by Elsevier in Human Pathology
- Vol. 30 (4) , 474-476
- https://doi.org/10.1016/s0046-8177(99)90125-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The hepatic stellate (Ito) cell: its role in human liver diseaseVirchows Archiv, 1997
- Fetal Megakaryocytic Dyshemopoiesis in Down Syndrome: Association with Hepatic and Pancreatic FibrosisPediatric Pathology, 1993
- Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesisBlood, 1992
- Severe perinatal liver disease and down syndrome: An apparent relationshipHuman Pathology, 1991
- Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseasesHepatology, 1991
- The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosisBlood, 1990
- Perinatal Visceral Fibrosis Accompanying the Megakaryoblastic Leukemoid Reaction of Down SyndromePediatric Pathology, 1990
- Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.Journal of Biological Chemistry, 1986
- A Neonate with Down’s Syndrome and Transient Abnormal Myelopoiesis: Serial Blood and Bone Marrow StudiesBlood, 1970